2023 World Conference on Lung Cancer (Posters)-EP14.03. Is Subxiphoid Uniportal Video-Assisted Thoracoscopic Mediastinal Surgery Safe, Minimally Invasive, and Radical?

EP14.03. Is Subxiphoid Uniportal Video-Assisted Thoracoscopic Mediastinal Surgery Safe, Minimally Invasive, and Radical? - PDF(Abstract)

Back to course

Pdf Summary

This study evaluates the safety, invasiveness, and curability of a new surgical approach called subxiphoid uniportal video-assisted thoracoscopic surgery (subxiphoid uniVATS) for anterior mediastinal tumors and myasthenia gravis (MG). The researchers performed the surgery on 28 patients between July 2016 and March 2023, and retrospectively reviewed the intraoperative and short to mid-term results.<br /><br />The results show that the surgeries included thymectomy, extended thymectomy, tumor extirpation, and biopsy, with pathological diagnoses including thymoma, thymic cyst, mature teratoma, and others. Six patients required conversion to other approaches due to factors such as bleeding, pneumoperitoneum, and technical difficulty. The median duration of postoperative hospital stay was 6.6 days and six patients experienced postoperative complications.<br /><br />However, the study found that postoperative pain in patients who underwent the surgery with subxiphoid uniVATS was relatively low. The patients' pain levels, as indicated by the Numerical Rating Scale, were consistently low in the days following the surgery. All patients are alive and no recurrence has been observed in patients with thymoma to date.<br /><br />Based on these results, the researchers conclude that subxiphoid uniVATS may be a safe and less invasive procedure for anterior mediastinal tumors and MG. However, they highlight the importance of improving surgical techniques, anticipating intraoperative problems, and effectively addressing them. The study suggests that further research and advancements in this surgical approach are necessary to enhance its effectiveness and safety.<br /><br />Overall, this study demonstrates the potential benefits of subxiphoid uniVATS in the treatment of thoracic tumors and MG, indicating the importance of ongoing advancements in surgical techniques for improved outcomes in these conditions.

Asset Subtitle

Yu Mori

Meta Tag

Speaker Yu Mori

Topic Other Thoracic Malignancy

Keywords

subxiphoid uniportal video-assisted thoracoscopic surgery

anterior mediastinal tumors

myasthenia gravis

safety

invasiveness

curability

thymectomy

thymoma

postoperative complications

surgical techniques